Yeni inhalasyon ajanlarının olumsuz etkileri ve farklı bir anestezik: Xenon

Son yıllarda intravenöz anestezikler ve kullanım tekniklerine dair gelişmeler yaşanmasına karşın, inhalasyon anestezikleri halen klinik anestezi uygulamalarının yapıtaşları olmaya devam etmektedirler. İdeal bir anestezik gaz özelliğinin tümünü içermeseler de, yeni inhalasyon ajanları olan sevoşuran ve desşuranın, eski inhalasyon ajanlarıyla karşılaştırıldığında bazı üstünlükleri olduğu bilinmektedir. Ancak kullanımları arttıkça bu iki ajana ait olumsuz etkilerin görülme oranları da artmaktadır. Bu derlemede sevoşuran ve desşuranın olumsuz etkileri ile ve yeni bir inhalasyon anesteziği olan xenon`un etkileri tartışılacaktır.
Anahtar Kelimeler:

Xenon, Anestezikler, inhalasyon

Adverse effects of new inhalation agents and a different anesthetic: Xenon

In recent years, despite developments in the type and use of intravenous anesthetics, inhalational anesthetics are still the corner stones of clinical anesthesia. Newer inhalational anesthetic agents like sevoflurane and desflurane, which are known to have particular advantages, do not include all the features of an ideal anesthetic when compared to old inhalational agents. However, as their usability increases, incidences of adverse effects increase as well. In this review, some adverse effects of sevoflurane and desflurane and the new inhalational anesthetic agent xenon will be discussed.

___

  • 1. Keijzer C, Perez RS, de Lange JJ. Carbon monoxide production from desflurane and six types of carbon dioxide absorbents in a patient model. Acta Anaesthesiol Scand 2005; 49:815-8.
  • 2. Berry PD, Sessler DI, Larson MD. Severe carbon monoxide poisoning during desflurane anesthesia. Anesthesiology 1999; 90:613-6.
  • 3. Fang ZX, Eger EI 2nd, Laster MJ, Chortkoff BS, Kondel L, Ionescu P. Carbon monoxide production from degradation of desflurane, enflurane, isoflurane, halothane, and sevoflurane by soda lime and baralime. Anesth Analg 1995; 80:1187-93.
  • 4. Keijzer C, Perez RS, De Lange JJ. Carbon monoxide production from five volatile anesthetics in dry sodalime in a patient model: halothane and sevoflurane do produce carbon monoxide; temperature is a poor predictor of carbon monoxide production BMC Anesthesiol 2005; 5:6.
  • 5. Frinf EJ Jr, Nogami WM, Morgan SE, Salmon RC. High carboxyhemoglobin concentrations occur in swine during desflurane anesthesia in the presence of partially dried carbon dioxide absorbents. Anesthesiology 1997; 87:308-16.
  • 6. Bonome C, Belda J, Alvarez-Refojo F, et alSoro M, Fernandez-Goti C, Cortes A. Low-flow anesthesia and reduced animal size increase carboxyhemoglobin levels in swine during desflurane and isoflurane breakdown in dried soda lime. Anesth Analg 1999; 89:909-16.
  • 7. Baxter PJ, Kharasch ED. Rehydration of desiccated Baralyme prevents carbon monoxide formation from desflurane in an anesthesia machine Anesthesiology 1997;86:1061-5.
  • 8. Holak EJ, Mei DA, Dunning MB ve ark. Carbon monoxide production from sevoflurane breakdown: modeling of exposures under clinical conditions. Anesth Analg 2003; 96:757-64.
  • 9. Fatheree RS, Leighton BL. Acute respiratory distress syndrome after an exothermic Baralyme-sevoflurane reaction. Anesthesiology 2004;101:531-3.
  • 10. Laster M, Roth P, Eger EI II. Fires from the interaction of anesthetics with desiccated absorbent. Anesth Analg 2004; 99:769-74.
  • 11. Laster MJ, Eger EI 2nd. Temperatures in soda lime during degradation of desflurane, isoflurane, and sevoflurane by desiccated soda lime. Anesth Analg 2005; 101:753-7.
  • 12. Wu J, Previte JP, Adler E, Myers T, Balls J, Gunter JB. Spontaneous ignition, explosion, and fire with sevoflurane and barium hydroxide lime. Anesthesiology 2004; 101:534-7.
  • 13. Castro BA, Freedman LA, Craig WL, Lynch C 3rd. Explosion within an anesthesia machine: Baralyme, high fresh gas flows and sevoflurane concentration. Anesthesiology 2004; 101:537-9.
  • 14. Kobayashi S, Bito H, Morita K, Katoh T, Sato S. Amsorb Plus and Dragersorb Free, two new-generation carbon dioxide absorbents that produce a low compound A concentration while providing sufficient CO2 absorption capacity in simulated sevoflurane anesthesia. J Anesth 2004; 18:277-81.
  • 15. Mazze RI, Callan CM, Galvez ST, Delgado-Herrera L, Mayer DB. The effects of sevoflurane on serum creatinine and blood urea nitrogen concentrations: a retrospective, twenty-two-center, comparative evaluation of renal function in adult surgical patients. Anesth Analg 2000; 90:683-8.
  • 16. Mazze RI, Woodruff RE, Heerdt ME. Isoniazide-induced enflurane, desfluorination in humans. Anesthesiology 1982; 57: 5-128.
  • 17. Gonsowski CT, Laste MJ, Eger EI, Ferrell LD, Kerschmann RL. Toxicity of Compound A in rats. Effect of a 3-hour administration. Anesthesiology 1994; 80:556.
  • 18. Gentz BA, Malan TP Jr. Renal toxicity with sevoflurane: a storm in a teacup? Drugs 2001; 61:2155-62.
  • 19. Altuntas TG, Zager RA, Kharasch ED. Cytotoxicity of S-conjugates of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl) vinyl ether (Compound A) in a human proximal tubular cell line. Toxicol Appl Pharmacol 2003; 15:55-65.
  • 20. Kharasch ED, Frink EJ Jr, Zager R, Bowdle TA, Artru A, Nogami WM et al. Assessment of low-flow sevoflurane and isoflurane effects on renal function using sensitive markers of tubular toxicity Anesthesiology 1997 ;86:1238-53.
  • 21. Ebert TJ, Frink EJ, Kharasch ED. Absence of biochemical evidence for renal and hepatic dysfunction after 8 hours of 1.25 minimum alveolar concentration sevoflurane anesthesia in volunteers. Anesthesiology 1998; 88:601–10.
  • 22. Eger EI 2nd, Gong D, Koblin DD ve ark. Dose-related biochemical markers of renal injury after sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg 1997; 85:1154–63.
  • 23. Artru AA. Renal effects of sevoflurane during conditions of possible increased risk. J Clin Anesth 1998; 10:531-8.
  • 24. Berghaus TM, Baron A, Geier A, Lamerz R, Paumgartner G. Hepatotoxicity following desflurane anesthesia. Hepatology 1999; 29:613-4.
  • 25. Chung PC, Chiou SC, Lien JM, Li AH, Wong CH. Reproducible hepatic dysfunction following separate anesthesia with sevoflurane and desflurane. Chang Gung Med J 2003; 26:357-62.
  • 26. Martin JL, Plevak DJ, Flannery KD ve ark. Hepatotoxicity after desflurane anesthesia Anesthesiology 1995; 83:1125-9.
  • 27. Tung D, Yoshida EM, Wang CS, Steinbrecher UP. Severe desflurane hepatotoxicity after colon surgery in an elderly patient. Can J Anaesth 2005; 52:133-6.
  • 28. Ogawa M, Doi K, Mitsufuji T, Satoh K, Takatori T. Drug induced hepatitis following sevoflurane anesthesia in a child. Masui 1991; 40:1542-5.
  • 29. Shichinohe Y, Masuda Y, Takahashi H ve ark. A case of postoperative hepatic injury after sevoflurane anesthesia. Masui 1992; 41:1802-5.
  • 30. Watanabe K, Hatakenaka S, Ikemune K, Chigyo Y, Kubozono T, Arai T. A case of suspected liver dysfunction induced by sevoflurane anesthesia. Masui 1993; 42:902-5.
  • 31. Gonzalo Pascual V, Forner Gonzalez A, Salvador E, Forns Benhart X, Miquel Morena R, Bruguera C›rtada M. Severe acute hepatitis after anesthesia with sevoflurane. Gastroenterol Hepatol 2005; 28:361-2.
  • 32. Reich A, Everding AS, Bulla M, Brinkmann OA, Van Aken H. Hepatitis after sevoflurane exposure in an infant suffering from primary hyperoxaluria type 1. Anesth Analg 2004; 99:370-2.
  • 33. Eger EI 2nd, Koblin DD, Bowland T ve ark. Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg 1997; 84:160-8.
  • 34. Iwanaga Y, Komatsu H, Yokono S, Ogli K. Serum glutathione Stransferase alpha as a measure of hepatocellular function following prolonged anaesthesia with sevoflurane and halothane in paediatric patients. Paediatr Anaesth. 2000;10:395-8.
  • 35. Aono J, Ueda W, Mamiya K, Takimoto E, Manabe M. Greater incidence of delirium during recovery from sevoflurane anesthesia in preschool boys. Anesthesiology 1997; 87: 1298–300.
  • 36. Lerman J. Inhalational anesthetics. Paediatr Anaesth 2004; 14:380-3.
  • 37. Cohen IT, Finkel JC, Hannallah RS, Hummer KA, Patel KM. Rapid emergence does not explain agitation following sevoflurane anaesthesia in infants and children: a comparison with propofol. Paediatr Anaesth 2003; 13:63-7.
  • 38. Cravero J, Surgenor S, Whalen K. Emergence agitation in paediatric patients after sevoflurane anaesthesia and no surgery: a comparison with halothane. Paediatr Anaesth 2000; 10:419-24.
  • 39. Uezono S, Goto T, Terui K ve ark. Emergence agitation after sevoflurane versus propofol in pediatric patients. Anesth Analg 2000; 91:563-6.
  • 40. Welborn LG, Hannallah RS, Norden JM, Ruttimann UE, Callan CM. Comparison of emergence and recovery characteristics of sevoflurane, desflurane, and halothane in pediatric ambulatory patients. Anesth Analg 1996; 83:917-20.
  • 41. Valley RD, Freid EB, Bailey AG ve ark. Tracheal extubation of deeply anesthetized pediatric patients: a comparison of desflurane and sevoflurane. Anesth Analg 2003; 96:1320-4.
  • 42. Cohen IT, Drewsen S, Hannallah RS. Propofol or midazolam do not reduce the incidence of emergence agitation associated with desflurane anaesthesia in children undergoing adenotonsillectomy. Paediatr Anaesth 2002; 12: 604-9.
  • 43. Obata R, Yasumi Y, Suzuki A, Nakajima Y, Sato S. Rhabdomyolysis in association with Duchenne’s muscular dystrophy. Can J Anaesth 1999; 46: 564–66.
  • 44. Takahashi H, Shimokawa M, Sha K ve ark. Sevoflurane can induce rhabdomyolysis in Duchenne’s muscular dystrophy. Masui 2002; 51: 190–2.
  • 45. Hoenemann CW, Halene-Holtgraeve TB, Booke M ve ark. Delayed onset of malignant hyperthermia in desflurane anesthesia. Anesth Analg 2003; 96:165-7.
  • 46. Papadimos TJ, Almasri M, Padgett JC, Rush JEA. A suspected case of delayed onset malignant hyperthermia with desflurane anesthesia. Anesth Analg 2004; 98:548-9.
  • 47. Uskova AA, Matusic BP, Brandom BW. Desflurane, malignant hyperthermia, and release of compartment syndrome. Anesth Analg 2005; 100:1357-60.
  • 48. Ciofolo MJ, Reiz S. Circulatory effects of volatile anesthetic agents. Minerva Anestesiol 1999; 65:232-8.
  • 49. Picker O, Schwarte LA, Schindler AW, Scheeren TW. Desflurane increases heart rate independent of sympathetic activity in dogs. Eur J Anaesthesiol 2003; 20:945-51.
  • 50. Gurkan Y, Canatay H, Agacdiken A, Ural E, Toker K. Effects of halothane and sevoflurane on QT dispersion in paediatric patients. Paediatr Anaesth 2003;13:223-7.
  • 51. Karagoz AH, Basgul E, Celiker V, Aypar U. The effect of inhalational anaesthetics on QTc interval. Eur J Anaesthesiol 2005; 22:171-4.
  • 52. Guler N, Kati I, Demirel CB, Bilge M, Eryonucu B, Topal C. The effects of volatile anesthetics on the Q-Tc interval. J Cardiothorac Vasc Anesth 2001; 15:188-91.
  • 53. Whyte SD, Booker PD, Buckley DG. The effects of propofol and sevoflurane on the QT interval and transmural dispersion of repolarization in children. Anesth Analg 2005; 100:71-7.
  • 54. Loeckinger A, Kleinsasser A, Maier S ve ark. Sustained prolongation of the QTc interval after anesthesia with sevoflurane in infants during the first 6 months of life. Anesthesiology 2003; 98: 639–42.
  • 55. Yildirim H, Adanir T, Atay A, Katircioglu K, Savaci S. The effects of sevoflurane, isoflurane and desflurane on QT interval of the ECG. Eur J Anaesthesiol 2004; 21:566-70.
  • 56. Owczuk R, Wujtewicz MA, Sawicka W, Lasek J, Wujtewicz M. The Influence of desflurane on QTc interval. Anesth Analg 2005; 101:419-22.
  • 57. Constant I, Dubois MC, Piat V, Moutard ML, McCue M, Murat I. Changes in electroencephalogram and autonomic cardiovascular activity during induction of anesthesia with sevoflurane compared with halothane in children. Anesthesiology 1999; 91:1604–15.
  • 58. Vakkuri A, Yli-Hankala A, Sarkela M ve ark. Sevoflurane mask induction of anaesthesia is associated with epileptiform EEG in children. Acta Anaesthesiol Scand 2001; 45:805–11.
  • 59. Boutin F, Bonnet A, Cros AM. Occurrence of epileptiform crisis in child under sevoflurane anaesthesia. Ann Fr Anesth Reanim 2005;24:559-60.
  • 60. Constant I, Seeman R, Murat I. Sevoflurane and epileptiform EEG changes. Pediatric Anesthesia 2005; 15: 266–74.
  • 61. Yli-Hankala A, Vakkuri A, Sarkela M, Lindgren L, Kortilla K, Jantti V. Epileptiform electroencephalogram during mask induction of anesthesia with sevoflurane. Anesthesiology 1999; 91: 1596–603.
  • 62. Kaisti KK, Jaaskelainen SK, Rinne JO, Metsahonkala L, Scheinin H. Epileptiform discharges during 2 MAC sevoflurane anesthesia in two healthy volunteers. Anesthesiology 1999; 91: 1952–55.
  • 63. Holmstrom A, Akeson J. Desflurane increases intracranial pressure more and sevoflurane less than isoflurane in pigs subjected to intracranial hypertension J Neurosurg Anesthesiol 2004;16:136-43.
  • 64. Sponheim S, Skraastad O, Helseth E, Due-Tonnesen B, Aamodt G, Breivik H. Effects of 0.5 and 1.0 MAC isoflurane, sevoflurane and desflurane on intracranial and cerebral perfusion pressures in children. Acta Anaesthesiol Scand 2003; 47:932-8.
  • 65. Vakkuri AP, Seitsonen ER, Jantti VH ve ark. A rapid increase in the inspired concentration of desflurane is not associated with epileptiform encephalogram. Anesth Analg 2005; 101:396-400.
  • 66. TerRiet MF, DeSouza GJ, Jacobs JS ve ark. Which is most pungent: isoflurane, sevoflurane or desflurane? Br J Anaesth 2000; 85:305-7.
  • 67. O'Keeffe NJ, Healy TE. The role of new anesthetic agents. Pharmacol Ther 1999; 84:233-48.
  • 68. Goff MJ, Arain SR, Ficke DJ, Uhrich TD, Ebert TJ. Absence of bronchodilation during desflurane anesthesia: a comparison to sevoflurane and thiopental. Anesthesiology 2000; 93:404-8.
  • 69. Karlsen KL, Persson E, Wennberg E, Stenqvist O. Anaesthesia, recovery and postoperative nausea and vomiting after breast surgery. A comparison between desflurane, sevoflurane and isoflurane anaesthesia. Acta Anaesthesiol Scand 2000; 44:489-93.
  • 70. Gupta A, Stierer T, Zuckerman R, Sakima N, Parker SD, Fleisher LA. Comparison of recovery profile after ambulatory anesthesia with propofol, isoflurane, sevoflurane and desflurane: a systematic review. Anesth Analg 2004; 98:632-41.
  • 71. Macario A, Dexter F, Lubarsky D. Meta-analysis of trials comparing postoperative recovery after anesthesia with sevoflurane or desflurane. Am J Health Syst Pharm 2005;62:63-8.
  • 72. Jellish WS, Owen K, Edelstein S, Fluder E, Leonetti JP. Standard anesthetic technique for middle ear surgical procedures: a comparison of desflurane and sevoflurane. Otolaryngol Head Neck Surg 2005;133:269-74.
  • 73. Kleinschmidt S, Grundmann U, Rauber K, Bauer M. Anesthesia with remifentanil combined with desflurane or sevoflurane in lumbar intervertebral disk operations. Anaesthesiol Reanim 2000;25:151-7.
  • 74. Kurpiers EM, Scharine J, Lovell SL. Cost-effective anesthesia: desflurane versus propofol in outpatient surgery. AANA J 1996; 64:69-75.
  • 75. Ozkose Z, Ercan B, Unal Y ve ark. Inhalation versus total intravenous anesthesia for lumbar disc herniation: comparison of hemodynamic effects, recovery characteristics, and cost. J Neurosurg Anesthesiol 2001;13:296-302.
  • 76. Eberhart LH, Bernert S, Wulf H, Geldner G. Pharmacoeconomical model for cost calculation using a study on prophylaxis of nausea and vomiting in the postoperative phase as an example. Cost effectiveness analysis of a tropisetron supplemented desflurane anaesthesia in comparison to a propofol total intravenous anaesthesia (TIVA) Anaesthesist 2002;51:475-81.
  • 77. Fombeur PO, Tilleul PR, Beaussier MJ, Lorente C, Yazid L, Lienhart AH. Cost-effectiveness of propofol anesthesia using targetcontrolled infusion compared with a standard regimen using desflurane. Am J Health Syst Pharm 2002; 59:1344-50.
  • 78. Odin I, Feiss P. Low flow and economics of inhalational anaesthesia. Best Pract Res Clin Anaesthesiol 2005; 19:399-413.
  • 79. Nakata Y, Goto T, Morita S. Clinical pharmacology of xenon. Int Anesthesiol Clin 2001; 39:63-75.
  • 80. Hecker K, Baumert JH, Horn N, Rossaint R. Xenon, a modern anaesthesia gas. Minerva Anestesiol 2004; 70: 255-60.
  • 81. Sanders RD, Ma D, Maze M. Xenon: elemental anaesthesia in clinical practice. Br Med Bull 2005; 71:115-35.
  • 82. Tonner PH. Xenon: one small step for anaesthesia? Curr Opin Anaesthesiol 2006;19:382-4.
  • 83. Weiskopf RB. Xenon anesthesia. Anesthesiology 2000; 92:865-70.
  • 84. Goto T. Is there a future for xenon anesthesia. Can J Anesth 2002; 49:335-8.
  • 85. Goto T, Nakata Y, Morita S. How does xenon produce anesthesia? A perspective from electrophysiological studies. Int Anesthesiol Clin 2001; 39:85-94.
  • 86. Coburn M, Kunitz O, Baumert JH ve ark. Randomized controlled trial of the haemodynamic and recovery effects of xenon or propofol anaesthesia. Br J Anaesth 2005; 94:198-202.
  • 87. Goto T, Saito H, Shinkai M, Nakata Y, Ichinose F, Morita S. Xenon provides faster emergence from anesthesia than does nitrous oxide-sevoflurane or nitrous oxide-isoflurane. Anesthesiology 1997; 86:1273-8.
  • 88. Dingley J, King R, Hughes L ve ark. Exploration of xenon as a potential cardiostable sedative: a comparison with propofol after cardiac surgery. Anaesthesia 2001; 56:829-35.
  • 89. Bedi A, Murray JM, Dingley J, Stevenson MA, Fee JP. Use of xenon as a sedative for patients receiving critical care. Crit Care Med 2003; 31:2470-7.
  • 90. Goto T, Nakata Y, Morita S. The minimum alveolar concentration of xenon in the elderly is sex-dependent. Anesthesiology 2002; 97:1129-32.
  • 91. Petersen-Felix S, Luginbuhl M, Schnider TW, Curatolo M, Arendt-Nielsen L, Zbinden AM. Comparison of the analgesic potency of xenon and nitrous oxide in humans evaluated by experimental pain. Br J Anaesth 1998; 81:742-7.
  • 92. Rossaint R, Reyle-Hahn M, Schulte Am Esch J ve ark. Multicenter randomized comparison of the efficacy and safety of xenon and isoflurane in patients undergoing elective surgery. Anesthesiology 2003; 98:6-13.
  • 93. Sanders RD, Maze M. Xenon: from stranger to guardian. Curr Opin Anaesthesiol 2005; 18:405-11.
  • 94. Kunitz O, Baumert JH, Hecker K ve ark. Xenon does not prolong neuromuscular block of rocuronium. Anesth Analg 2004; 99: 1398-401.
  • 95. Nakata Y, Goto T, Ishiguro Y ve ark. Minimum alveolar concentration (MAC) of xenon with sevoflurane in humans. Anesthesiology 2001; 94:611-4.
  • 96. Weber NC, Toma O, Wolter JI ve ark. The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-epsilon and p38 MAPK. Br J Pharmacol 2005; 144:123-32.
  • 97. Preckel B, Weber NC, Sanders RD, Maze M, Schlack W. Molecular mechanisms transducing the anesthetic, analgesic, and organprotective actions of xenon. Anesthesiology 2006; 105:187-97.
  • 98. Goto T, Hanne P, Ishiguro Y, Ichinose F, Niimi Y, Morita S. Cardiovascular effects of xenon and nitrous oxide in patients during fentanyl-midazolam anaesthesia. Anaesthesia 2004; 59:1178-83.
  • 99. Clark JA, Ma D, Homi HM, Maze M, Grocott HP. Xenon and the inflammatory response to cardiopulmonary bypass in the rat. J Cardiothorac Vasc Anesth 2005; 19:488-93.
  • 100. Bein B, Turowski P, Renner J ve ark. Comparison of xenon-based anaesthesia compared with total intravenous anaesthesia in high risk surgical patients. Anaesthesia 2005; 60:960-7.
  • 101. Luttropp HH, Romner B, Perhag L, Eskilsson J, Fredriksen S, Werner O. Left ventricular performance and cerebral haemodynamics during xenon anaesthesia. A transoesophageal echocardiography and transcranial Doppler sonography study. Anaesthesia 1993; 48:1045-9.
  • 102. Yao L, Nemoto EM, Boston JR, Yonas H. Effect of 80% xenon whole blood flow and metabolism in awake monkeys. J Neurosurg Anesthesiol 1992;4: 268-71.
  • 103. Schmidt M, Marx T, Kotzerke J ve ark. Cerebral and regional organ perfusion in pigs during xenon anaesthesia. Anaesthesia 2001; 56:1154-9.
  • 104. Schmidt M, Marx T, Armbruster S, Reinelt H, Schirmer U. Effect of Xenon on elevated intracranial pressure as compared with nitrous oxide and total intravenous anesthesia in pigs. Acta Anaesthesiol Scand 2005; 49:494-501.
  • 105.Wilhelm S, Ma D, Maze M, Franks NP. Effects of xenon on in vitro and in vivo models of neuronal injury. Anesthesiology 2002; 96:1485-91.
  • 106. Homi HM, Yokoo N, Ma D ve ark. The neuroprotective effect of xenon administration during transient middle cerebral artery occlusion in mice. Anesthesiology 2003; 99:876-81.
  • 107. Schmidt M, Marx T, Gloggl E, Reinelt H, Schirmer U. Xenon attenuates cerebral damage after ischemia in pigs. Anesthesiology 2005; 102:929-36.
  • 108. Gruss M, Bushell TJ, Bright DP, Lieb WR, Mathie A, Franks NP. Two-pore-domain k+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol 2004; 65:443-52.
  • 109. Fujii Y. Respiratory effects of xenon. Int Anesthesiol Clin 2001; 39:95-103.
  • 110. Schwarzkopf K, Schreiber T, Gaser E ve ark. The effects of xenon or nitrous oxide supplementation on systemic oxygenation and pulmonary perfusion during one-lung ventilation in pigs. Anesth Analg 2005; 100:335-9.
  • 111. Calzia E, Stahl W, Handschuh T ve ark. Continuous arterial PO2 and PCO2 measurements in swine during nitrous oxide and xenon elimination: prevention of diffusion hypoxia. Anesthesiology 1999;90:829-34.
  • 112. Nakata Y, Goto T, Niimi Y, Morita S. Cost analysis of xenon anesthesia: a comparison with nitrous oxide-isoflurane and nitrous oxide-sevoflurane anesthesia. J Clin Anesth 1999;11:477-81.
  • 113. Saito H, Saito M, Goto T, Morita S. Priming of anesthesia circuit with xenon for closed circuit anesthesia. Artif Organs 1997; 21: 70-2.
  • 114. Dingley J, Findlay GP, Foex BA, Mecklenburg J, Esmail M, Little RA. A closed Xenon anesthesia delivery system. Anesthesiology 2001; 94: 173-77.
  • 115. Lane GA, Nahrwold ML, Tait AR, Taylor-Busch M, Cohen PJ, Beaudoin AR. Anesthetics as teratogens: nitrous oxide is fetotoxic, xenon is not. Science 1980; 210: 899-901.
  • 116. Froeba G, Marx T, Pazhur J ve ark. Xenon does not trigger malignant hyperthermia in susceptible swine. Anesthesiology 1999; 91:1047-52.
  • 117. Schucht F. Production of anaesthetic gases and environment. Appl Cardiopulmonary Pathophysiol 2000; 9:154–5.
Anestezi Dergisi-Cover
  • ISSN: 1300-0578
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 1993
  • Yayıncı: Betül Kartal
Sayıdaki Diğer Makaleler

Nalokson, postoperatif analjezide kullanılan morfinin immünosüpresif etkilerini inhibe ediyor mu?

Hüseyin FİDAN, Deniz ÖZZEYBEK, Zahide ELAR, Mehmet Ali ÖKTEM

Yeni inhalasyon ajanlarının olumsuz etkileri ve farklı bir anestezik: Xenon

Zerrin ÖZKÖSE

Düşük akımlı anestezi uygulamasında desfluran ve izofluranın FA/FI=%80 oranına erişme zamanlarının ve hemodinamik etkilerinin karşılaştırılması

Asu ÖZGÜLTEKİN, Hatice ÇELİK, GÜLDEM TURAN, Emine DİNÇER, Nur AKGÜN

Alzheimer hastalığı ve anestezi

Elif BAŞGÜL, Heves KARAGÖZ

Derlenme sürelerinde bispektral indeks değerlerine karşılık gelen entropi değerlerinin belirlenmesi

Canan BALCI, Gökhan AKBULUT, Arif Halil İBİŞ, Yüksel ARIKAN

Deksmedetomidinin stres cevaba ve desfluran ihtiyacına etkisi

Nermin KILIÇASLAN, Sinan GÜRSOY, Kenan KAYGUSUZ, Taner ERSENCAN, İBRAHİM HALUK KAFALI, Caner MİMAROĞLU

Bebekte ilginç bir santral venöz kateter yanlış yerleşimi: (Olgu sunumu)

Murat TEKİN, İsmail KATI, Yakup TOMAK

Ensefalosel ve zor entübasyon (Olgu sunumu)

Serdar EPÖZDEMİR, Ali Aydın ALTUNKAN, Nurcan DORUK, Özer Zeliha ALTUNKAN, Uğur ORAL

Dev glottik polibi olan hastada laringeal maske ile hava yolu kontrolü (Olgu sunumu)

Mesut ŞENER, Sündüz ASLAN, Haluk YAVUZ, Ayda TÜRKÖZ, Gülnaz ARSLAN

Yoğun bakım ünitesinde tedavi edilen hastalarda strese neden olan faktörlerin cinsiyetler açısından değerlendirilmesi

ŞULE AKIN ENES, Anış ARIBOĞAN